Ingevity Corp
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.2B | $1.7B | $1.4B |
| Gross profit | $461.5M | $464.8M | $445.0M | $570.1M | $512.8M |
| Operating income | $418.7M | $425.9M | $423.2M | $452.6M | $422.2M |
| Cost of revenue | $706.1M | $735.3M | $770.5M | $1.1B | $878.7M |
| Cash from operations | $331.2M | $128.6M | $205.1M | $313.4M | $293.3M |
| Capital expenditure | $57.7M | $77.6M | $109.8M | $142.5M | $103.8M |
| Free cash flow | $273.5M | $51.0M | $95.3M | $170.9M | $189.5M |
| Share repurchases | $56.3M | $0 | $92.1M | $145.2M | $109.4M |
| Impairments | $109.3M | $0 | $0 | $0 | $0 |
| Total assets | $1.7B | $2.0B | $2.6B | $2.7B | $2.5B |
| Total liabilities | $1.6B | $1.8B | $2.0B | $2.0B | $1.8B |
| Total debt | $1.2B | $1.4B | $1.5B | $1.5B | $1.3B |
Shares outstanding 34.8M · Free float 94.7%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.